Related Experiment Videos
[Behçet's disease: a vascular function study by the venostasis test and DDAVP infusion]
La Revue De Medecine Interne
|March 1, 1985
Summary
Recurrent thromboembolic events in Behçet's disease may stem from a plasma inhibitor of the fibrinolytic system. Acute exacerbations showed abnormal venostasis and DDAVP test responses in patients.
Area of Science:
- Vascular Biology
- Hematology
- Rheumatology
Context:
- Behçet's disease is a rare multisystem inflammatory disorder.
- Recurrent thromboembolic accidents are a significant cause of morbidity and mortality in Behçet's disease patients.
- The underlying mechanisms of thrombosis in Behçet's disease are not fully understood.
Purpose:
- To investigate the hemostatic and fibrinolytic system responses in patients with Behçet's disease.
- To identify potential factors contributing to recurrent thromboembolic events.
Summary:
- Ten patients with Behçet's disease were studied, with five experiencing acute exacerbations.
- Abnormal responses to the venostasis test and desmopressin (DDAVP) were observed during acute phases.
- Elevated Factor VIII activity post-DDAVP in all patients suggests normal endothelial response but points to a possible fibrinolytic system inhibitor in some.
Impact:
- This study provides insights into the pathophysiology of thrombosis in Behçet's disease.
- Findings suggest a potential therapeutic target for preventing thromboembolic complications.
- Further research into fibrinolytic inhibitors could improve management strategies for Behçet's disease.